Clicky

Meghan Highlights Depression in Pregnancy, an Overlooked Danger

Oprah Winfrey’s interview with Meghan and Harry has clearly become a spark for international discussions about racism and the state of Britain’s royal family. And it has brought new attention to another issue as well. Meghan’s revelation of her mental anguish during and after her first pregnancy, including thoughts of suicide so significant that she

Meghan Highlights Depression in Pregnancy, an Overlooked Danger Read More »

Major Depressive Disorder – Epidemiology Forecast to 2029

New York, March 12, 2021 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Major Depressive Disorder – Epidemiology Forecast to 2029” – https://www.reportlinker.com/p06034994/?utm_source=GNW MDD is characterized by persistent feelings of sadness, anger, irritability or frustration, loss of interest in activities, and overeating or loss of appetite that can last from days to months,

Major Depressive Disorder – Epidemiology Forecast to 2029 Read More »

Over 1 in 5 health care workers experience depression and anxiety during the pandemic, study says

(CNN) — Staggering numbers of health care workers — more than one in five — have experienced anxiety, depression or post-traumatic stress disorder during the pandemic, new research has revealed. Health care workers have been working for long hours under strenuous conditions. Because of this, Nathaniel Scherer, co-lead author of the systematic review and meta-analysis

Over 1 in 5 health care workers experience depression and anxiety during the pandemic, study says Read More »

Nexstim Gives an Update on its Promising Treatment Results of Major Depressive Disorder Helsinki Stock Exchange:NXTMH

Press Release, Helsinki, 12 March 2021 at 10.00 (EET) Nexstim Gives an Update on its Promising Treatment Results of Major Depressive Disorder Nexstim Plc (NXTMH:HEX, NXTMS:STO) (“Nexstim” or “Company”) reports very promising clinical outcomes of the 159 patients who have completed Nexstim SmartFocus® rTMS treatment with Nexstim NBT® system for major depressive disorder (MDD). Treatment

Nexstim Gives an Update on its Promising Treatment Results of Major Depressive Disorder Helsinki Stock Exchange:NXTMH Read More »

Depression risk higher after stroke vs. heart attack and female vs. male stroke survivors

DALLAS, March 11, 2021 — Stroke patients were nearly 50% more likely than heart attack patients to develop depression, and female stroke patients had a higher risk of depression than their male counterparts, according to two preliminary studies by the same research group to be presented at the American Stroke Association’s International Stroke Conference 2021.

Depression risk higher after stroke vs. heart attack and female vs. male stroke survivors Read More »

Manhattan’s depressed office space values bring the new reality home

To understand the steep road to recovery, focus on one number: $928. That’s the average price per square foot that investors were willing to pay for shares in the city’s publicly traded landlords over the three years before the pandemic. Today, the implied per-square-foot value of Empire State Realty Trust is just $436, according to a

Manhattan’s depressed office space values bring the new reality home Read More »

MIJ 821: Developed by Novartis for Treatment Resistant Depression – Global Emerging Insight and Market Forecast 2021-2030 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “MIJ 821 – Emerging Insight and Market Forecast – 2030” report has been added to ResearchAndMarkets.com’s offering. MIJ 821 acts as NR2B N-Methyl D-Aspartate receptor modulators and is being developed by Novartis for Treatment Resistant Depression. It was originally developed by Cadent Therapeutics but Novartis licensed exclusively from Cadent in 2015. “MIJ 821

MIJ 821: Developed by Novartis for Treatment Resistant Depression – Global Emerging Insight and Market Forecast 2021-2030 – ResearchAndMarkets.com Read More »

Navigate the challenges of anxiety, depression, and trauma with Purpose, PLLC!

Kedisha Dixon, MSW, RP, the owner of Purpose PLLC joins us to talk about navigating the challenges of life. Purpose PLLC is a safe place to navigate the challenges of anxiety, depression, trauma, family conflict or whatever “purpose robbers” that are at play. Call Kedisha at 719-749-1143 and follow her on social media @PurposePLLC. >>Click

Navigate the challenges of anxiety, depression, and trauma with Purpose, PLLC! Read More »

Mediating role of pain between depression and pain severity

Hee Jun Kim,1 Hyunjeong Park,2 Hee-Soon Juon3 1Research Institute of Nursing Science, College of Nursing, Ajou University, Suwon, 16499, Republic of Korea; 2Department of Nursing, Towson University, Towson, MD, 21252, USA; 3Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA, 19107, USA Correspondence: Hee Jun KimResearch Institute of Nursing Science, College of Nursing, Ajou University,

Mediating role of pain between depression and pain severity Read More »